P1-(adenosine-5')-P3-(glucose-6)triphosphate

ID: ALA609929

Chembl Id: CHEMBL609929

PubChem CID: 46876869

Max Phase: Preclinical

Molecular Formula: C16H26N5O18P3

Molecular Weight: 669.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2C1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]2O[C@@H](O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H26N5O18P3/c17-13-7-14(19-3-18-13)21(4-20-7)15-11(25)9(23)5(36-15)1-34-40(28,29)38-42(32,33)39-41(30,31)35-2-6-8(22)10(24)12(26)16(27)37-6/h3-6,8-12,15-16,22-27H,1-2H2,(H,28,29)(H,30,31)(H,32,33)(H2,17,18,19)/t5-,6+,8+,9-,10-,11-,12+,15?,16-/m1/s1

Standard InChI Key:  LDHIOGOAFFVWDH-MINQEEAFSA-N

Associated Targets(non-human)

Hk1 Hexokinase type I (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hk2 Hexokinase type II (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hk3 Hexokinase type III (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 669.32Molecular Weight (Monoisotopic): 669.0486AlogP: -3.80#Rotatable Bonds: 11
Polar Surface Area: 358.28Molecular Species: ACIDHBA: 20HBD: 10
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.90CX Basic pKa: 4.92CX LogP: -7.38CX LogD: -12.22
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.10Np Likeness Score: 1.20

References

1. Hampton A, Hai TT, Kappler F, Chawla RR..  (1982)  Species- or isozyme-specific enzyme inhibitors. 6. Synthesis and evaluation of two-substrate condensation products as inhibitors of hexokinases and thymidine kinases.,  25  (7): [PMID:7108896] [10.1021/jm00349a007]

Source